Get started
Intervacc ABIntervacc ABIntervacc AB

Intervacc AB

No trades
See on Supercharts
OverviewFinancialsNewsMindsSeasonals

Chart


Full chart

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪29.53 M‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.0524 EUR
Net income (FY)
‪−6.57 M‬ EUR
Revenue (FY)
‪1.02 M‬ EUR
Shares float
‪329.77 M‬
Beta (1Y)
1.27

About Intervacc AB


Sector
Health Technology
Industry
Biotechnology
CEO
Jonas Sohlman
Website
intervacc.com
Headquarters
Stockholm
Founded
1983
ISIN
SE0009607252
FIGI
BBG00LGMM1D6
Intervacc AB engages in the development of novel veterinary vaccines. It markets veterinary vaccines through its subsidiary Nordvacc Läkemedel AB. The company was founded by Jan-Ingmar Flock, Bengt Guss, Kenneth Janzon, and Rune Bergman in 2001 and is headquartered in Stockholm, Sweden.

Check out other big names from the same industry as 2E9.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on SWB exchange Intervacc AB stocks are traded under the ticker 2E9.
2E9 reached its all-time high on Jun 9, 2022 with the price of 3.3903 EUR, and its all-time low was 0.0561 EUR and was reached on Jan 30, 2025. View more price dynamics on 2E9 chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track Intervacc AB financials in yearly and quarterly reports right on TradingView.
Intervacc AB is going to release the next earnings report on Nov 19, 2025. Keep track of upcoming events with our Earnings Calendar.
2E9 earnings for the last quarter are 0.00 EUR per share, whereas the estimation was −0.02 EUR resulting in a 74.66% surprise. The estimated earnings for the next quarter are −0.01 EUR per share. See more details about Intervacc AB earnings.
Intervacc AB revenue for the last quarter amounts to ‪625.13 K‬ EUR, despite the estimated figure of ‪562.62 K‬ EUR. In the next quarter, revenue is expected to reach ‪559.53 K‬ EUR.
2E9 net income for the last quarter is ‪−1.59 M‬ EUR, while the quarter before that showed ‪−1.21 M‬ EUR of net income which accounts for −31.31% change. Track more Intervacc AB financial stats to get the full picture.
No, 2E9 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Intervacc AB EBITDA is ‪−4.94 M‬ EUR, and current EBITDA margin is −649.35%. See more stats in Intervacc AB financial statements.
Like other stocks, 2E9 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Intervacc AB stock right from TradingView charts — choose your broker and connect to your account.